Relative bioavailability of chlorothiazide from mucoadhesive compacts in pigs

AAPS PharmSciTech

Volumn 10, Issue 4, 2009, Pages 1331-1335

  Neelam, Karunakar ^a   Mahalingam, Ravichandran ^a   Birudaraj, Raj ^b   Alfredson, Tom ^b   Anne, Pratap ^a   Li, Xiaoling ^a   Jasti, Bhaskara R ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b Pharmaceutics Department   (United States)

Author keywords

Bioavailability; Chlorothiazide; Mucoadhesive compacts; Pigs

Indexed keywords

CHLOROTHIAZIDE; WATER;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CATHETER; CONTROLLED STUDY; DIET RESTRICTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; JUGULAR VEIN; MALE; MAXIMUM PLASMA CONCENTRATION; MUCOADHESION; NONHUMAN; PRECIPITATION; SINGLE DRUG DOSE; STOMACH TUBE; SUSPENSION; SWINE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CHLOROTHIAZIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DELAYED-ACTION PREPARATIONS; DIURETICS; FEMALE; MALE; SUSPENSIONS; SWINE;

EID: 75549087653     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9332-0     Document Type: Article

References (29)

1. Jusko WJ, Levy G. Absorption, protein binding, and elimination of riboflavin. In: Rivlin RS, editor. Riboflavin. New York: Plenum; 1975.
2. S Christensen 1973 The biological fate of riboflavin in mammals. A survey of literature and own investigations Acta Pharm Toxicol 32 1 72
3. D Deleu G Ebinger Y Michotte 1973 Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa Eur J Clin Pharmacol 41 453 8 10.1007/BF00626368
4. Marathe PH, Wen Y, Norton J, Greene DS, Barbhaiya RH, Wilding IR. Effect of altered gastric emptying and gastrointestinal motility on bioavailability of metformin. AAPS Annual Meeting, New Orleans, LA; 1999.
5. N Vidon S Chaussade M Noel C Franchisseur B Huchet JJ Bernier 1988 Metformin in the digestive tract Diabetes Res Clin Pract 4 223 9 10.1016/S0168-8227(88)80022-6 1:CAS:528:DyaL1cXhsVehtLo%3D 3359923
6. Sweetman SC. Martindale: the complete drug reference. 35th ed. London: Pharmaceutical; 2007. p. 1116.
7. ER Dennis RB Theodore 1979 Apparent dose-dependent absorption of chlorothiazide in dogs J Pharmacokinet Biopharm 7 463 9 10.1007/BF01062388 (Pubitemid 10194532)
8. SS Davis 2005 Formulation strategies for absorption windows Drug Discov Today 10 249 57 10.1016/S1359-6446(04)03351-3 1:CAS:528:DC%2BD2MXhtlajsb4%3D 15708743 (Pubitemid 40222218)
9. AJ Moes 1993 Gastroretentive dosage forms Crit Rev Ther Drug Carrier Syst 10 143 95 1:CAS:528:DyaK3sXlt1Cqsbc%3D 8370085
10. A Streubel K Siepmann R Bodmeier 2006 Gastroretentive drug delivery systems Expert Opin Drug Deliv 3 2 217 33 10.1517/17425247.3.2.217 1:CAS:528:DC%2BD28XhvVKnsLs%3D 16506949 (Pubitemid 43338093)
11. A Streubel J Siepmann R Bodmeier 2006 Drug delivery to the upper small intestine window using gastroretentive technologies Curr Opin Pharmacol 6 5 501 8 10.1016/j.coph.2006.04.007 1:CAS:528:DC%2BD28XpsVWrsLw%3D 16890020 (Pubitemid 44340666)
12. M Jaimini AC Rana YS Tanwar 2007 Formulation and evaluation of famotidine floating tablets Curr Drug Deliv 4 1 51 5 10.2174/156720107779314730 1:CAS:528:DC%2BD2sXitlamtbo%3D 17269917 (Pubitemid 46066414)
13. N Rouge 1998 Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol Pharm Acta Helv 73 2 81 7 10.1016/S0031-6865(97)00050-2 1:CAS:528:DyaK1cXktFKht7o%3D 9700936 (Pubitemid 28327969)
14. A Streubel J Siepmann R Bodmeier 2002 Floating microparticles based on low density foam powder Int J Pharm 241 2 279 92 10.1016/S0378-5173(02)00241-7 1:CAS:528:DC%2BD38XkvFelt7g%3D 12100855 (Pubitemid 34718029)
15. A Streubel J Siepmann R Bodmeier 2003 Multiple unit gastroretentive drug delivery systems: a new preparation method for low density microparticles J Microencapsul 20 3 329 47 10.1080/0265204021000058384 1:CAS:528: DC%2BD3sXkvFCqsL0%3D 12881114 (Pubitemid 36621475)
16. R Talukder R Fassihi 2004 Gastroretentive delivery systems: hollow beads Drug Dev Ind Pharm 30 4 405 12 10.1081/DDC-120030935 1:CAS:528: DC%2BD2cXislGgtr4%3D 15132183 (Pubitemid 38987183)
17. L Whitehead 1998 Floating dosage forms: an in vivo study demonstrating prolonged gastric retention J Control Release 55 1 3 12 10.1016/S0168-3659(97) 00266-6 1:CAS:528:DyaK1cXmslWjsr0%3D 9795000 (Pubitemid 28477559)
18. R Groning C Cloer RS Muller 2006 Development and in vitro evaluation of expandable gastroretentive dosage forms based on compressed collagen sponges Pharmazie 61 7 608 12 1:STN:280:DC%2BD28vmsFOjsg%3D%3D 16889068
19. R Groning 2007 Compressed collagen sponges as gastroretentive dosage forms: in vitro and in vivo studies Eur J Pharm Sci 30 1 1 6 10.1016/j.ejps.2006.08.003 17101267 (Pubitemid 44908920)
20. KA Klausner 2003 Expandable gastroretentive dosage forms J Control Release 90 2 143 62 10.1016/S0168-3659(03)00203-7 1:CAS:528:DC%2BD3sXksFKktbk%3D 12810298 (Pubitemid 36700451)
21. D Duchene G Ponchel 1992 Principle and investigation of the bioadhesion mechanism of solid dosage forms Biomaterials 13 10 709 14 10.1016/0142-9612(92) 90132-8 1:CAS:528:DyaK38XmtF2ru7o%3D 1420717
22. Y Huang 2000 Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces J Control Release. 65 1-2 63 71 10.1016/S0168-3659(99)00233-3 1:CAS:528:DC%2BD3cXhtl2qsrY%3D 10699271 (Pubitemid 30122916)
23. G Ponchel J Irache 1998 Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract Adv Drug Deliv Rev 34 2-3 191 219 10.1016/S0169-409X(98)00040-4 1:CAS:528:DyaK1cXnsFWlt78%3D 10837678 (Pubitemid 28535112)
24. SL Tao TA Desai 2005 Gastrointestinal patch systems for oral drug delivery Drug Discov Today 10 13 909 15 10.1016/S1359-6446(05)03489-6 1:CAS:528:DC%2BD2MXlsl2rtbk%3D 15993810 (Pubitemid 40922789)
25. C Atuma 2001 The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo Am J Physiol Gastrointest Liver Physiol 280 5 G922 9 1:CAS:528:DC%2BD3MXjsVahtr0%3D 11292601
26. A Eytan EL Klausner F Michael H Amnon 2003 Expandable gastroretentive dosage forms J Control Release 90 143 62 10.1016/S0168-3659(03)00203-7 (Pubitemid 36700451)
27. SS Davis L Illum M Hinchcliffe 2001 Gastrointestinal transit of dosage forms in the pig J Pharm Pharmacol 53 33 9 10.1211/0022357011775163 1:CAS:528:DC%2BD3MXht1Shsr4%3D 11206190 (Pubitemid 32123697)
28. M Ravichandran BR Jasti R Birudaraj D Stefanidis R Killion T Alfredson, et al. 2009 Evaluation of polyethylene oxide compacts as gastroretentive delivery systems AAPS Pharm Sci Tech 10 1 98 103 10.1208/s12249-008-9182-1
29. L Kagan A Hoffman 2008 Selection of drug candidates for gastroretentive dosage forms: pharmacokinetics following continuous intragastric mode of administration in a rat mode Eur J Pharm Biopharm 69 238 46 10.1016/j.ejpb.2007. 10.019 1:CAS:528:DC%2BD1cXktlGltLc%3D 18068342